MARSHALL WACE, LLP - ORAMED PHARMACEUTICALS INC ownership

ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 89 filers reported holding ORAMED PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.23 and the average weighting 0.0%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of ORAMED PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$23,006
-94.9%
10,553
-71.8%
0.00%
-100.0%
Q4 2022$449,909
+143.2%
37,399
+31.6%
0.00%
Q3 2022$185,000
+105.6%
28,409
+45.6%
0.00%
Q2 2022$90,000
-23.1%
19,509
+68.7%
0.00%
-100.0%
Q1 2021$117,000
-24.5%
11,563
-68.4%
0.00%0.0%
Q4 2020$155,000
+1.3%
36,632
-37.5%
0.00%0.0%
Q3 2020$153,000
-10.0%
58,648
+21.5%
0.00%0.0%
Q2 2020$170,000
-27.7%
48,260
-37.6%
0.00%
-50.0%
Q1 2020$235,000
-59.9%
77,361
-32.0%
0.00%
-50.0%
Q4 2019$586,000113,7060.00%
Other shareholders
ORAMED PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
BML Capital Management, LLC 1,355,925$2,955,9172.56%
Susquehanna International Group Ltd. 113,526$247,4870.14%
XTX Topco Ltd 151,620$330,5320.07%
Corsair Capital Management 47,256$103,0180.04%
Diametric Capital, LP 14,314$31,2050.02%
Draper Asset Management, LLC 5,320$11,5980.02%
ETF MANAGERS GROUP, LLC 68,940$150,2890.01%
BOURGEON CAPITAL MANAGEMENT LLC 5,627$12,2670.00%
TWO SIGMA INVESTMENTS, LP 506,255$1,103,6360.00%
Apollon Wealth Management, LLC 20,000$43,6000.00%
View complete list of ORAMED PHARMACEUTICALS INC shareholders